SANTA CLARA, Calif.--(BUSINESS WIRE)--Affymetrix Inc. (Nasdaq:AFFX) today announced that the Republic of Korea’s National Institute of Health (NIH) and Center for Disease Control and Prevention is expanding the Korean Association Resource (KARE) project and using the Affymetrix Genome-Wide Human SNP Array 6.0 to analyze 13,000 additional samples. The expansion of the project enables the Korea NIH to increase the overall genetic power of the project to validate previous findings and to identify new genetic variations associated with lifestyle-related complex diseases that are prevalent in Korea.
